ALKERMES | ALKS - 现金及等价物

股票价格

33.31

每天变化

-0.60 -1.77%

每月一次

13.42%

每年

19.65%

Q2 预测

32.32

金融业

USD

USD 2.49B

现金及等价物

USD 388.57M

USD 46.21M

USD 1.93B

USD 543.44M

USD 71.6M

股息收益率

0

USD -10.95M

USD 100.31M

1.8K

EPS每股收益

USD 0.29

股本和储备

USD 1.82B

USD 338.34M

债务利息支出

USD 12.28M

USD 11.94M

USD 285.82M

USD 5.49B

USD 49.34M

USD 326.44M

USD -10.95M

普通股股本

USD 165.61M

19.54

USD 100.74M

USD 384.5M

销售和管理费用

USD 187.2M

USD 196.63M

贸易债权人

USD 107.95M

应收帐款人

USD 334.03M

	现金及等价物	更改		日
AbbVie	USD 5.23B		400M	2025-12
Acadia Pharmaceuticals	USD 819.69M		27.33M	2025-12
ALKERMES	USD 388.57M		227.88M	2025-12
Amgen	USD 9.13B		316M	2025-12
Biogen	USD 3.01B		854.3M	2025-12
BioMarin Pharmaceutical	USD 1.31B		61.57M	2025-12
Bristol-Myers Squibb	USD 10.21B		5.52B	2025-12
Coherus Biosciences	USD 88.88M		14.47M	2025-12
Eli Lilly	USD 7.27B		2.52B	2025-12
Gilead Sciences	USD 7.56B		234M	2025-12
Heron Therapeutics	USD 43.07M		26.55M	2025-09
Ionis Pharmaceuticals	USD 2.68B		437M	2025-12
J&J	USD 21.69B		1.98B	2026-03
Malin Corporation	EUR 62.1M		26.4M	2024-12
Merck	USD 18.17B		10.16B	2025-09
Minerva Neurosciences	USD 82.3M		70.02M	2025-12
Nektar Therapeutics	USD 15.12M		25.92M	2025-12
Neurocrine Biosciences	USD 713M		372.8M	2025-12
Otsuka Holdings	JPY 411.11B		3.62B	2025-06
Pfizer	USD 1.34B		295M	2025-09
Regeneron Pharmaceuticals	USD 18.87B		16.36B	2025-12
Vertex Pharmaceuticals	USD 6.61B		321.1M	2025-12